MeiraGTx's stock rises on small Parkinson's gene therapy dataset

Max Gelman

Senior Editor

MeiraGTx unveiled results from a small dataset for its Parkinson’s disease gene therapy on Tuesday morning, causing its shares $MGTX to jump by as much …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

MeiraGTx's stock rises on small Parkinson's gene therapy dataset

Max Gelman

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

J&J trims pipeline, including two mid-stage neuroscience studies

Forbion raises €2.1B for two new biotech funds after series of company exits

Pfizer partners with molecular glue startup Triana in $49M upfront deal

Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex

Exclusive: Biotech tools company raises $75M for protein manufacturing tech

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

MeiraGTx's stock ris­es on small Parkin­son's gene ther­a­py dataset

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

MeiraGTx's stock rises on small Parkinson's gene therapy dataset